Blog

Over 200 Life Sciences organizations worldwide are adopting ArisGlobal’s LifeSphere Safety™ multi-tenant cloud platform to achieve E2B(R3) compliance by November 2017 EMA deadline. Within that platform, ArisGlobal’s LifeSphere Safety MultiVigilance™ solution leads the way in transforming safety case management through technology and regulatory expertise.

Artificial intelligence (AI), machine learning, deep learning, natural language processing – in short, cognitive computing, is changing the pharmacovigilance world…

Chicago, Illinois, July 19, 2017 – Dr. Vivek Ahuja, Vice President, Global Pharmacovigilance, ArisGlobal will present “Automation in ICSR Processing…

The clinical trial sector witnessed a lot of action in 2016. Pharmaceutical establishments are increasing their focus on this branch…

Silos have long plagued the life sciences industry, and nowhere is this more notable than with how information and data…

ArisGlobal LifeSphere® the most complete cognitive computing platform transforms every primary function of the product lifecycle including pharmacovigilance, clinical operations, clinical data management, regulatory affairs and medical communications

CUSTOMER BACKGROUND With a history dating back to the late 1980s, this western U.S. biopharmaceutical company has focused its development…

CUSTOMER BACKGROUND Customer is a leading global pharmaceutical company headquartered in Eurasia. The company is committed to increasing access to…

Customer Background Incorporated in 1993 as a subsidiary of Biocon Limited, Syngene is a leading custom research and manufacturing organization,…

The client, a mid-tier biotechnology company with products in a range of therapeutic areas, was struggling with an all-too-familiar challenge: How to effectively collect, organize, triage and archive the large volume of inbound potential AE (Adverse Event) and ADR (Adverse Drug Reaction) reports they received for case processing and reporting.